Profound Medical Corp
TSX:PRN
Income Statement
Earnings Waterfall
Profound Medical Corp
Revenue
|
7.2m
USD
|
Cost of Revenue
|
-2.8m
USD
|
Gross Profit
|
4.4m
USD
|
Operating Expenses
|
-33m
USD
|
Operating Income
|
-28.6m
USD
|
Other Expenses
|
47k
USD
|
Net Income
|
-28.6m
USD
|
Income Statement
Profound Medical Corp
Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+158%
|
2
+101%
|
4
+62%
|
4
-3%
|
3
-15%
|
2
-30%
|
2
-8%
|
3
+39%
|
3
+9%
|
3
+9%
|
4
+24%
|
4
+1%
|
5
+14%
|
7
+36%
|
7
+11%
|
7
-6%
|
8
+23%
|
9
+4%
|
7
-21%
|
8
+10%
|
7
-8%
|
6
-7%
|
7
+4%
|
7
+7%
|
7
-6%
|
6
-5%
|
7
+12%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+171%
|
1
+39%
|
1
+82%
|
1
-7%
|
1
-22%
|
1
-16%
|
1
-27%
|
1
+92%
|
1
+15%
|
2
+12%
|
2
+51%
|
2
-11%
|
2
+8%
|
4
+54%
|
3
-2%
|
3
-5%
|
4
+24%
|
4
-12%
|
3
-18%
|
3
+6%
|
3
-9%
|
3
+4%
|
3
+2%
|
4
+26%
|
4
+3%
|
4
-1%
|
4
+13%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(4)
|
(7)
|
(9)
|
(9)
|
(12)
|
(9)
|
(10)
|
(12)
|
(12)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(16)
|
(15)
|
(15)
|
(16)
|
(17)
|
(20)
|
(20)
|
(22)
|
(22)
|
(24)
|
(27)
|
(29)
|
(33)
|
(34)
|
(35)
|
(36)
|
(33)
|
(35)
|
(34)
|
(33)
|
(33)
|
|
Selling, General & Administrative |
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(8)
|
(10)
|
(11)
|
(12)
|
(12)
|
(13)
|
(14)
|
(16)
|
(18)
|
(19)
|
(20)
|
(20)
|
(18)
|
(18)
|
(17)
|
(17)
|
(19)
|
|
Research & Development |
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(7)
|
(8)
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(7)
|
0
|
(8)
|
(10)
|
(11)
|
0
|
(15)
|
(16)
|
(16)
|
(15)
|
(15)
|
(15)
|
(13)
|
(14)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(9)
|
(9)
|
(9)
|
(7)
|
(5)
|
(2)
|
(10)
|
(3)
|
(3)
|
(3)
|
(15)
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
0
|
|
Operating Income |
(4)
N/A
|
(7)
-66%
|
(9)
-19%
|
(9)
-2%
|
(12)
-36%
|
(9)
+22%
|
(10)
-8%
|
(12)
-17%
|
(12)
-3%
|
(13)
-6%
|
(14)
-8%
|
(14)
+2%
|
(14)
-6%
|
(15)
-7%
|
(15)
-1%
|
(16)
-1%
|
(14)
+10%
|
(14)
+1%
|
(14)
-5%
|
(15)
-3%
|
(18)
-19%
|
(17)
+1%
|
(18)
-3%
|
(19)
-5%
|
(21)
-9%
|
(23)
-12%
|
(25)
-11%
|
(30)
-19%
|
(31)
-2%
|
(32)
-4%
|
(33)
-2%
|
(30)
+10%
|
(32)
-7%
|
(30)
+4%
|
(29)
+6%
|
(29)
+0%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(3)
|
(3)
|
1
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
1
|
0
|
(3)
|
(6)
|
(5)
|
(3)
|
0
|
0
|
3
|
4
|
3
|
5
|
2
|
(0)
|
0
|
|
Non-Reccuring Items |
0
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(1)
|
(1)
|
(1)
|
(4)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Pre-Tax Income |
(8)
N/A
|
(13)
-49%
|
(14)
-7%
|
(13)
+1%
|
(15)
-11%
|
(10)
+33%
|
(11)
-9%
|
(12)
-14%
|
(13)
-3%
|
(13)
-5%
|
(15)
-10%
|
(14)
+1%
|
(15)
-6%
|
(16)
-7%
|
(16)
+3%
|
(16)
0%
|
(14)
+11%
|
(14)
+1%
|
(15)
-6%
|
(15)
-2%
|
(15)
-3%
|
(16)
-5%
|
(17)
-7%
|
(22)
-23%
|
(26)
-23%
|
(28)
-7%
|
(28)
0%
|
(31)
-8%
|
(31)
-2%
|
(30)
+3%
|
(29)
+3%
|
(28)
+3%
|
(27)
+5%
|
(28)
-5%
|
(29)
-2%
|
(29)
+1%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
Income from Continuing Operations |
(9)
|
(12)
|
(13)
|
(13)
|
(14)
|
(10)
|
(11)
|
(12)
|
(13)
|
(13)
|
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(14)
|
(14)
|
(15)
|
(15)
|
(16)
|
(17)
|
(18)
|
(22)
|
(26)
|
(28)
|
(28)
|
(31)
|
(31)
|
(30)
|
(29)
|
(29)
|
(27)
|
(29)
|
(29)
|
(29)
|
|
Net Income (Common) |
(9)
N/A
|
(12)
-40%
|
(13)
-7%
|
(13)
+2%
|
(14)
-11%
|
(10)
+30%
|
(11)
-9%
|
(12)
-14%
|
(13)
-3%
|
(13)
-5%
|
(15)
-10%
|
(15)
+0%
|
(15)
-6%
|
(16)
-7%
|
(16)
+3%
|
(16)
-1%
|
(14)
+11%
|
(14)
+1%
|
(15)
-6%
|
(15)
-2%
|
(16)
-3%
|
(17)
-6%
|
(18)
-8%
|
(22)
-20%
|
(26)
-22%
|
(28)
-7%
|
(28)
+0%
|
(31)
-9%
|
(31)
-2%
|
(30)
+4%
|
(29)
+3%
|
(29)
+2%
|
(27)
+5%
|
(29)
-5%
|
(29)
-2%
|
(29)
+2%
|
|
EPS (Diluted) |
-39.54
N/A
|
-9.43
+76%
|
-3.29
+65%
|
-5.41
-64%
|
-3.59
+34%
|
-2.52
+30%
|
-2.74
-9%
|
-2.97
-8%
|
-2.28
+23%
|
-2.39
-5%
|
-2.36
+1%
|
-2.36
N/A
|
-1.98
+16%
|
-1.52
+23%
|
-1.47
+3%
|
-1.6
-9%
|
-1.32
+18%
|
-1.3
+2%
|
-1.37
-5%
|
-1.37
N/A
|
-1.07
+22%
|
-1.03
+4%
|
-0.96
+7%
|
-1.25
-30%
|
-1.3
-4%
|
-1.38
-6%
|
-1.37
+1%
|
-1.5
-9%
|
-1.52
-1%
|
-1.46
+4%
|
-1.41
+3%
|
-1.38
+2%
|
-1.3
+6%
|
-1.37
-5%
|
-1.39
-1%
|
-1.35
+3%
|